Heal, a Los Angeles-based company that provides on-demand doctor house call service in California, raises $26.9M Series A at a $110M post-money valuation
Jonathan Shieber / TechCrunch :
Context & Ripple Effects
Heal's $26.9M Series A in 2016 was an early bet that doctor house calls could be rebuilt as an on-demand consumer service, starting in California. The bet aged well: by 2020 the same model had attracted serious capital and payer money, with Humana investing $100M alongside a partnership with Heal itself.
The category also broadened beyond the house call — Ready raised a $54M Series C for at-home medical care while Lemonaid Health scaled an online-only on-demand alternative, meaning Heal now competes on delivery mode as much as on convenience.
First-order effects
- Heal gets runway to expand its California house-call footprint and hire physicians ahead of rivals still proving unit economics.
- Payers watching the space get a live test of whether home visits reduce costlier downstream claims — the question Humana answered with its own checkbook four years later.
Second-order effects
- Competitors are forced to pick a lane: Ready doubles down on home-based care at Series C scale, while Lemonaid bets patients will accept virtual-only visits at lower price points.
- Insurers shift from passive reimbursement to strategic investing, using equity stakes in services like Heal to steer members toward cheaper care settings.
Third-order effects
- If payer-backed home care keeps scaling, the clinic stops being the default point of care and insurers become the distribution channel deciding which delivery mode — house call, virtual, or office — wins each patient interaction.
The trend: Healthcare delivery is moving into the home, with insurers acting as both customers and capital partners to the startups making the shift.